Chemoradiotherapy clinical trials

Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

This study is testing if a new combination of treatments, including chemotherapy, immunotherapy, and surgery or radiation, can improve outcomes for people with certain types of advanced lung cancer. It aims to see if patients live longer without their cancer returning.